Poststroke depression: Psychopharmacological considerations

Perspectives in Psychiatric Care

Volumn 40, Issue 4, 2004, Pages 167-170

  Antai Otong, Deborah ^a  

^a NONE

Author keywords

Depression; Stroke

Indexed keywords

CITALOPRAM; FLUOXETINE; NORTRIPTYLINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTICHOLINERGIC EFFECT; CARDIOTOXICITY; COMORBIDITY; COPING BEHAVIOR; DATA ANALYSIS; DEPRESSION; HUMAN; MEDICAL RECORD; MENTAL HEALTH; PATHOGENESIS; PREVALENCE; PSYCHIATRIC DIAGNOSIS; REVIEW; RISK FACTOR; SEDATION; SIDE EFFECT; STANDING; STROKE; TREATMENT OUTCOME;

EID: 15944405686     PISSN: 00315990     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1744-6163.2004.tb00014.x     Document Type: Review

References (31)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, text revision (4th ed., TR). Washington, DC: Author.
2. Andersen, G., Vestergaard, K., Rus, J.O., & Laurizen, L. (1994). Incidence of poststroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta Psychiatrica Scandinavia, 90, 190-195.
3. Aström, M., Adolfsson, R., & Asplund, K. (1993). Major depression in stroke patients: A 3-year longitudinal study. Stroke, 24, 976-982.
4. Bhogal, S.K., Teasall, R., Foley, N., & Speechley, M. (2004). Lesion location and poststroke depression: A systematic review of methodological limitations in the literature. Stroke, 35, 794-802.
5. Burvill, P.W., Johnson, G.A., Jamrozik, K.D., Anderson, C.S., Stewart-Wynne, E.G., & Chakera, T.M.H. (1995). Prevalence of depression after stroke: The Perth community stroke study. British Journal of Psychiatry, 166, 320-327.
6. Chemerinski, E., Robinson, R.G., & Kosier, J.T. (2001). Improved recovery in activities of daily living associated with remission of post-stroke depression. Stroke, 32, 113-117.
7. Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). "Mini-mental state:" A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
8. Fruehwald, S., Gatterbauer, E., Rehak, P., & Baumhackl, U. (2003). Early fluoxetine treatment of post-stroke depression. A three-month double-blind placebo-controlled study with open-label long-term follow up. Journal of Neurology, 250, 347-351.
9. Gainotti, G., Antonucci, G., Marra, C., & Paolucci, S. (2001). Relation between depression after stroke, antidepressant therapy, and functional recovery. Journal of Neurology, Neurosurgery, and Psychiatry, 71, 258-261.
10. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-62.
11. Hermann, N., Black, S.E., Lawrence, J., Szekely, C., & Szalai, J.B. (1998). The Sunnybrook stroke study. A prospective study of depressive symptoms and functional outcome. Stroke, 29, 618-624.
12. Ingles, J.J., Eskes, G.A., & Phillips, S.J. (1999). Fatigue after a stroke. Archives of Physical Medicine Rehabilitation, 80, 173-178.
13. Jorge, R.E., Robinson, R.G., Arndt, S., & Starkstein, S. (2003). Mortality and poststroke depression: A placebo-controlled trial of antidepressants. American Journal of Psychiatry, 160, 1823-1829.
14. Kertesz, A. (1982). The Western Aphasia Battery. New York: Grune & Stratton.
15. Kimura, M., Robinson, R.G., & Kosier, B.S. (2000). Treatment of cognitive impairment after poststroke depression. A double-blind treatment trial. Stroke, 31, 1482-1485.
16. Koenig, H.G. (1991). Depressive disorders in medical inpatients. American Family Physician, 44, 1243-1250.
17. Morris, P.L.P., Robinson, R.G., & Raphael, B. (1990). Prevalence and course of depressive disorders in hospitalized stroke patients. International Journal of Psychiatric Medicine, 20, 349-364.
18. Murata, Y., Kimura, M., & Robinson, R.G. (2000). Does cognitive impairment cause post-stroke depression? American Journal of Geriatrics, 8, 310-317.
19. Narushima, K., Kosier, J.T., & Robinson, R.G. (2002). Preventing post-stroke depression: A 12-week double-blind randomized treatment trial and 21-month follow up. Journal of Nervous and Mental Diseases, 190, 296-303.
20. Narushima, K., Kosier, J.T., & Robinson, R.G. (2003). A reappraisal of poststroke depression, intra-inter-hemisphere lesion location using meta-analysis. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 422-430.
21. Paolucci, S., Antonucci, G., Pratesi, L., Trabellesi, M., Grasso, M.G., & Lubich, S. (1999). Poststroke depression and its role in rehabilitation of inpatients. Archives of Physical Medicine Rehabilitation, 80, 985-990.
22. Rampello, L., Chiechio, S., Nicoletti, G., Alvano, A., Vecchio, I., Raffaele, R., & Malaguarnera, M. (2004). Prediction of the response to citalopram and reboxetine in poststroke depressed patients. Psychopharmacology, 173, 73-78.
23. Robinson, R.G. (1998). Treatment issues in poststroke depression. Depression and Anxiety, 8, 85-90.
24. Robinson, R.G. (2003). Poststroke depression: Prevalence, diagnosis, treatment and diseases progression. Biological Psychiatry, 54, 376-387.
25. Robinson, R.G., Schultz, S.K., Castillo, C., Kopel, T., & Kosier, T. (2000). Nortriptyline versus fluoxetine in the treatment of depression and in short term recovery after stroke: A placebo controlled, double-blind study. American Journal of Psychiatry, 157, 351-359.
26. Stamenkovic, M., Schlinder, S., & Kasper, S. (1996). Poststroke depression and fluoxetine. American Journal of Psychiatry, 153, 446-447.
27. Stolley, J.M., McCormick, C., & Hall, G.R. (2003). The client with delirium, dementia, amnestic and other cognitive disorders. In D. Antai-Otong (Ed.), Psychiatric nursing: Biological and behavioral concepts (pp. 407-445). Clifton Parks, NY: Delmar Thomsom.
28. Van de Meent, H., Geurts, A.C., & Van Limbeck, J. (2003). Pharmacologic treatment of poststroke depression: A systematic review of the literature. Topics in Stroke Rehabilitation, 10, 79-92.
29. Wade, D.T., Legh-Smith, J., & Hewer, R.A. (1987). Depressed mood after stroke: A community study of its frequency. British Journal of Psychiatry, 151, 200-205.
30. Wechsler, D. (1987). Wechsler memory scale-revised. New York: Psychological Corp.
31. Wiart, L., Petit, H., Joseph, P.A., Mazaux, J.M., & Barat, M. (2000). Fluoxetine in early poststroke depression. A double-blind placebo-controlled study. Stroke, 31, 1829-1832.